194 related articles for article (PubMed ID: 37236420)
21. Ocular signs predictive of tubercular uveitis.
Gupta A; Bansal R; Gupta V; Sharma A; Bambery P
Am J Ophthalmol; 2010 Apr; 149(4):562-70. PubMed ID: 20149341
[TBL] [Abstract][Full Text] [Related]
22. Pattern of Recurrent Inflammation following Anti-tubercular Therapy for Ocular Tuberculosis.
Multani PK; Modi R; Basu S
Ocul Immunol Inflamm; 2022 Jan; 30(1):185-190. PubMed ID: 32644846
[TBL] [Abstract][Full Text] [Related]
23. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
Kiran D; Podell BK; Chambers M; Basaraba RJ
Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
[TBL] [Abstract][Full Text] [Related]
24. [Observational study of QuantiFERON® management for ocular tuberculosis diagnosis: Analysis of 244 consecutive tests].
Amara A; Ben Salah E; Guihot A; Fardeau C; Touitoue V; Saadoun D; Bodaghi B; Sève P; Trad S
Rev Med Interne; 2021 Mar; 42(3):162-169. PubMed ID: 33143863
[TBL] [Abstract][Full Text] [Related]
25. Ocular Tuberculosis--A Clinical Conundrum.
Lee C; Agrawal R; Pavesio C
Ocul Immunol Inflamm; 2016; 24(2):237-42. PubMed ID: 26110355
[No Abstract] [Full Text] [Related]
26. The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area.
Tsui J; Ho M; Lui G; Li T; Chen L; Iu L; Brelen M; Young AL
Int Ophthalmol; 2021 Sep; 41(9):3199-3209. PubMed ID: 34037904
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis and treatment of tuberculous uveitis in a low endemic setting.
Vos AG; Wassenberg MW; de Hoog J; Oosterheert JJ
Int J Infect Dis; 2013 Nov; 17(11):e993-9. PubMed ID: 23706496
[TBL] [Abstract][Full Text] [Related]
28. Re: Agrawal et al.: Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1 (Ophthalmology. 2021;128:266-276).
Chawla R; Venkatesh P; Kumar V; Azad S
Ophthalmology; 2021 Dec; 128(12):e217. PubMed ID: 34503846
[No Abstract] [Full Text] [Related]
29. Re: Agrawal et al.: Collaborative Ocular Tuberculosis Study consensus guidelines on the management of tubercular uveitis-report 1: Guidelines for initiating antitubercular therapy in tubercular choroiditis (Ophthalmology. 2020 Jan 11;S0161-6420(20)30013-0. https://doi.org/10.1016/j.ophtha.2020.01.008 [Epub ahead of print]).
Venkatesh P; Chawla R; Kumar V
Ophthalmology; 2020 Nov; 127(11):e100-e101. PubMed ID: 32739182
[No Abstract] [Full Text] [Related]
30. Anti-tubercular therapy for intraocular tuberculosis: A systematic review and meta-analysis.
Kee AR; Gonzalez-Lopez JJ; Al-Hity A; Gupta B; Lee CS; Gunasekeran DV; Jayabalan N; Grant R; Kon OM; Gupta V; Westcott M; Pavesio C; Agrawal R
Surv Ophthalmol; 2016; 61(5):628-53. PubMed ID: 26970263
[TBL] [Abstract][Full Text] [Related]
31. Uveitis associated with latent tuberculosis: A comparative study of the impact of antitubercular therapy combined or not with systemic corticosteroids.
Nahon-Esteve S; Martel A; Maschi C; Alketbi M; Baillif S; Tieulie N
Eur J Ophthalmol; 2021 Sep; 31(5):2457-2466. PubMed ID: 33008274
[TBL] [Abstract][Full Text] [Related]
32. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
[TBL] [Abstract][Full Text] [Related]
33. Anti-tubercular therapy in the treatment of tubercular uveitis: A systematic review and meta-analysis.
Betzler BK; Putera I; Testi I; La Distia Nora R; Kempen J; Kon OM; Pavesio C; Gupta V; Agrawal R
Surv Ophthalmol; 2023; 68(2):241-256. PubMed ID: 36272559
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment for ocular tuberculosis among uveitis specialists: the international perspective.
Lou SM; Montgomery PA; Larkin KL; Winthrop K; Zierhut M; Rosenbaum JT;
Ocul Immunol Inflamm; 2015 Feb; 23(1):32-9. PubMed ID: 25615808
[TBL] [Abstract][Full Text] [Related]
35. Presumed tuberculous uveitis: diagnosis, management, and outcome.
Sanghvi C; Bell C; Woodhead M; Hardy C; Jones N
Eye (Lond); 2011 Apr; 25(4):475-80. PubMed ID: 21293496
[TBL] [Abstract][Full Text] [Related]
36. Bilateral interstitial keratitis and granulomatous uveitis of tubercular origin.
Kamal S; Kumar R; Kumar S; Goel R
Eye Contact Lens; 2014 Mar; 40(2):e13-5. PubMed ID: 23538732
[TBL] [Abstract][Full Text] [Related]
37. Visual and treatment outcomes of tubercular uveitis: a prospective case series from a referral hospital in Pakistan.
Ghauri MI; Iqbal N; Riaz SU; Irfan M; Kumar A; Mukarram MS
BMC Res Notes; 2019 Jul; 12(1):404. PubMed ID: 31307549
[TBL] [Abstract][Full Text] [Related]
38. Prospective head-to-head study comparing 2 commercial interferon gamma release assays for the diagnosis of tuberculous uveitis.
Ang M; Wong WL; Kiew SY; Li X; Chee SP
Am J Ophthalmol; 2014 Jun; 157(6):1306-14; 1314.e1-4. PubMed ID: 24508163
[TBL] [Abstract][Full Text] [Related]
39. Role of anti-tubercular therapy in uveitis with latent/manifest tuberculosis.
Bansal R; Gupta A; Gupta V; Dogra MR; Bambery P; Arora SK
Am J Ophthalmol; 2008 Nov; 146(5):772-9. PubMed ID: 18708180
[TBL] [Abstract][Full Text] [Related]
40. The utility of routine tuberculosis screening in county hospital patients with uveitis.
Hong BK; Khanamiri HN; Bababeygy SR; Rao NA
Br J Ophthalmol; 2014 Aug; 98(8):1091-5. PubMed ID: 24489378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
